Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Pharmalot
Health
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
In the Lab
STAT+

Two adversaries in the CRISPR patent battle meet — and look ahead

  • Usha Lee McFarling

By Usha Lee McFarling March 2, 2017

Reprints
CRISPR DNA Replacement
Alissa Ambrose/STAT

LA JOLLA, Calif. — Patent fight? What patent fight?

Two of the leading adversaries in the battle to own CRISPR, the powerful gene-editing tool, took the stage together at a genetic medicine conference here, and they couldn’t have been more polite — or more forward-looking.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Usha Lee McFarling

Usha Lee McFarling

National Science Correspondent

Usha Lee McFarling is a national science correspondent for STAT based in Los Angeles. She is examining health inequities and their toll.

Tags

‘I’m terrified’: Patients scramble for treatment after 13 ketamine…
‘I’m terrified’: Patients scramble for treatment after 13 ketamine clinics shut down
5 ways to address the shortage of health care…
5 ways to address the shortage of health care workers
When a patient nears the end, a feared therapy…
When a patient nears the end, a feared therapy can also comfort
Researchers devise new strategies to overcome a key CRISPR…
Researchers devise new strategies to overcome a key CRISPR flaw
Cerebral and other telehealth startups face new legal and…
Cerebral and other telehealth startups face new legal and regulatory challenges over ad models
Stanford scientist who broke genome sequencing record on what…
Stanford scientist who broke genome sequencing record on what faster diagnoses mean for patients

Recommended Stories